| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |